BIOMAT Database Logo BIOMAT Database Logo

Direct and indirect regulation of cardiac L-type calcium channels by beta-adrenoreceptor agonists. 1990

W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
II. Physiologisches Institut, Medizinische Fakultat, Universitat des Saarlandes, Homburg/Saar, FRG.

UI MeSH Term Description Entries
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000262 Adenylyl Cyclases Enzymes of the lyase class that catalyze the formation of CYCLIC AMP and pyrophosphate from ATP. Adenyl Cyclase,Adenylate Cyclase,3',5'-cyclic AMP Synthetase,Adenylyl Cyclase,3',5' cyclic AMP Synthetase,AMP Synthetase, 3',5'-cyclic,Cyclase, Adenyl,Cyclase, Adenylate,Cyclase, Adenylyl,Cyclases, Adenylyl,Synthetase, 3',5'-cyclic AMP
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015220 Calcium Channels Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue. Ion Channels, Calcium,Receptors, Calcium Channel Blocker,Voltage-Dependent Calcium Channel,Calcium Channel,Calcium Channel Antagonist Receptor,Calcium Channel Antagonist Receptors,Calcium Channel Blocker Receptor,Calcium Channel Blocker Receptors,Ion Channel, Calcium,Receptors, Calcium Channel Antagonist,VDCC,Voltage-Dependent Calcium Channels,Calcium Channel, Voltage-Dependent,Calcium Channels, Voltage-Dependent,Calcium Ion Channel,Calcium Ion Channels,Channel, Voltage-Dependent Calcium,Channels, Voltage-Dependent Calcium,Voltage Dependent Calcium Channel,Voltage Dependent Calcium Channels

Related Publications

W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
Regulation of cloned cardiac L-type calcium channels by cGMP-dependent protein kinase.
March 2000, The Journal of biological chemistry,
W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
[The progress of the calcium-dependent regulation on cardiac L-type calcium channels].
October 2013, Sheng li ke xue jin zhan [Progress in physiology],
W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
Regulation of cardiac sodium-calcium exchanger by beta-adrenergic agonists.
May 1996, Proceedings of the National Academy of Sciences of the United States of America,
W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
Alpha 2-adrenoreceptor stimulation does not inhibit L-type calcium channels in mouse pancreatic beta-cells.
June 1991, Bioscience reports,
W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
alpha1-beta interaction in voltage-gated cardiac L-type calcium channels.
April 1997, FEBS letters,
W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
Autoregulation of cardiac l-type calcium channels.
November 2009, Trends in cardiovascular medicine,
W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C.
December 2000, Circulation research,
W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
Regulation by L-type calcium channels of endocytosis: an overview.
October 2012, Journal of molecular neuroscience : MN,
W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids.
February 1999, Molecular pharmacology,
W Trautwein, and A Cavalie, and T J Allen, and Y M Shuba, and S Pelzer, and D Pelzer
Stimulation of cardiac L-type calcium channels by extracellular ATP.
May 2001, American journal of physiology. Cell physiology,
Copied contents to your clipboard!